![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||
Copyright © 2007 by the Genetics Society of America Chi Hotspot Activity in Escherichia coli Without RecBCD Exonuclease Activity: Implications for the Mechanism of Recombination Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1Corresponding author: Division of Basic Sciences, Fred Hutchinson Cancer Research Center, A1-162, 1100 Fairview Ave. North, P. O. Box 19024, Seattle, WA 98109. E-mail: gsmith/at/fhcrc.org Communicating editor: S. T. Lovett Received August 31, 2006; Accepted October 23, 2006. This article has been cited by other articles in PMC.Abstract The major pathway of genetic recombination and DNA break repair in Escherichia coli requires RecBCD enzyme, a complex nuclease and DNA helicase regulated by Chi sites (5′-GCTGGTGG-3′). During its unwinding of DNA containing Chi, purified RecBCD enzyme has two alternative nucleolytic reactions, depending on the reaction conditions: simple nicking of the Chi-containing strand at Chi or switching of nucleolytic degradation from the Chi-containing strand to its complement at Chi. We describe a set of recC mutants with a novel intracellular phenotype: retention of Chi hotspot activity in genetic crosses but loss of detectable nucleolytic degradation as judged by the growth of mutant T4 and λ phages and by assay of cell-free extracts. We conclude that RecBCD enzyme's nucleolytic degradation of DNA is not necessary for intracellular Chi hotspot activity and that nicking of DNA by RecBCD enzyme at Chi is sufficient. We discuss the bearing of these results on current models of RecBCD pathway recombination. HOMOLOGOUS genetic recombination is important for the faithful repair of double-strand breaks in DNA and for the generation of genetic diversity. In the bacterium Escherichia coli, the major (RecBCD) pathway of recombination and repair of linear double-strand (ds) DNA requires the unusually complex RecBCD enzyme. Composed of three subunits, the purified enzyme has at least six activities: DNA unwinding (helicase), ds exonuclease, single-stranded (ss) exonuclease, DNA-dependent ATPase, weak ss endonuclease, and loading of RecA protein onto ssDNA (reviewed by Kowalczykowski 2000; Smith 2001). The activity of RecBCD enzyme is regulated by Chi sites (5′-GCTGGTGG-3′), which were first recognized as hotspots of recombination in bacteriophage λ (reviewed by Smith 2001). The molecular basis of Chi's hotspot activity, the localized stimulation of intracellular recombination, is not clearly established because of the difficulty of inferring intracellular reactions from the properties of purified enzymes and DNA. Here, we describe multiple alleles of recC whose novel phenotype indicates that Chi hotspot activity can occur in the absence of extensive nucleolytic degradation. We discuss how these results bear on previously proposed models of Chi-stimulated recombination by the RecBCD pathway (Smith et al. 1981b; Thaler et al. 1988; Anderson and Kowalczykowski 1997a). A combination of both genetic and physical studies of RecBCD enzyme has led to the following picture (Figure 1
When Chi is properly encountered, the activities of purified RecBCD are changed in a manner that depends on the reaction conditions (Figure 1 In E. coli cells there is an excess of total Mg2+ over ATP, but most of the Mg2+ is bound, probably to nucleic acids (Moncany and Kellenberger 1981). The effective concentration of Mg2+ available to RecBCD enzyme is unknown, and therefore it is not clear how RecBCD acts at Chi in cells. To address this question, we have studied mutant forms of RecBCD enzyme that allow a comparison of the intracellular phenotypes and the properties of mutant RecBCD enzymes, either in unfractionated extracts or after purification. The novel phenotype of the class of recC mutants described here indicates that RecBCD exonuclease and therefore degradation up to Chi are not necessary for Chi's stimulation of recombination. MATERIALS AND METHODS Culture media: Rich media (broth and agar plates), containing Difco tryptone–yeast extract (LB) or Difco tryptone (TB), minimal medium agar (OMBG), and phage suspension medium (SM) are described by Cheng and Smith (1989). Ampicillin (100 μg/ml), streptomycin (50 μg/ml), tetracycline (25 μg/ml), and kanamycin (25 μg/ml) were used where appropriate. Bacterial and phage strains, plasmids, and genotype designations: Supplemental Tables S1 and S2 at http://www.genetics.org/supplemental/ list the E. coli strains and plasmids with their genotypes and sources. Genealogies are available upon request. Table 1 lists the E. coli rec and related mutations used here. All strains carry the recF143 mutation so that recombination is limited to the RecBCD pathway (Smith 1988). The genotype recBCD+ indicates recB+ recC+ recD+. Genotypes such as recC1041 imply recB+ recC1041 recD+ unless designated otherwise. For visual clarity, proteins are indicated with superscript allele numbers, such as RecBC1041D. Phage T4 and its gene 2 (amN51) mutant are described by Epstein et al. (1964) and Silverstein and Goldberg (1976). λ phages for Chi hotspot crosses contained b1453 (an int red gam deletion) plus susJ6 cI857 χ+D123 (strain 1081), χ+D123 susR5 (1082), susJ6 χ+76 cI857 (1083), and susJ6 χ+76 (1084) and are described by Stahl and Stahl (1977).
Strain constructions: E. coli strains were constructed by phage P1 transduction, transformation with plasmids, or by “recombineering” using appropriate mutant oligonucleotides (Integrated DNA Technologies, Coralville, IA, or Invitrogen, Carlsbad, CA) and electroporation of strain DY378 or HME63 (Thomason et al. 2005). Plasmid mutations were made by PCR-based strategies, some with the QuikChange kit (Stratagene, La Jolla, CA), and appropriate mutant oligonucleotides; details are available upon request. Plasmid and chromosomal mutations were confirmed by nucleotide sequencing of appropriate PCR products. For experiments with plasmid-borne deletions recC2710–2718, C2725, or C2726 (see Figure 3 kan), or V2659 (ΔrecBCD234) were made with DNA propagated in strain DH5α, purified, and used immediately.
Phage λ crosses and Chi activity: Crosses between λ phages 1081 and 1082 and between 1083 and 1084 were conducted, and Chi activity was determined as described by Stahl and Stahl (1977). The frequency of J+ R+ recombinant phages in the two crosses was determined by differential plating on strain C600 (supE44) for total phage and on strain 594 (sup+) for J+ R+ recombinants. The frequencies in the two crosses did not differ significantly: in 20 pairs of crosses the ratio of the frequencies was 1.1 ± 0.05 (mean ± SEM; our unpublished data). E. coli Hfr crosses: Crosses between the indicated recipient strain (F− hisG4 rpsL31) and donor strain V1306 (Hfr PO44 his+ rpsL+) were conducted as described by Schultz et al. (1983) with selection for His+ StrR (rpsL31) recombinants. The ratio of Hfr:F− cells in the matings was ~1:10. Recombinant frequencies are expressed as the number of recombinants per Hfr cell in the mating, corrected for viability of the recipient cells. Efficiency of plaque formation by phage: Cells were grown in TB broth to ~1 × l08/ml. Phage in SM (0.05 ml) were added to 0.1 ml of cell culture, and the mixture incubated at 37° for 15 min. Top agar (2.5 ml) was added, and the mixture poured onto a TB agar plate, which was incubated at 37° overnight. The efficiency of plaque formation is the titer on the strain tested divided by the titer on strain V67 (recB21) for testing haploid strains or strain V653 [ΔrecBCD232 (pSA21)] for testing plasmid-containing strains. RecBCD enzyme and reactions with DNA: Enzymes from wild-type and recC1041 cells were prepared as described by Amundsen et al. (2002), as were the DNA substrates and methods for assaying unwinding and nicking of linear dsDNA at Chi (Taylor et al. 1985). RESULTS Experimental background: recBCD mutant phenotypes and intracellular RecBCD enzyme activity: Mutations in the three genes encoding RecBCD produce a spectrum of phenotypes. Null mutations, including complete deletions, insertions, or early nonsense mutations, in recB and recC eliminate all activities of RecBCD. These mutants are recombination deficient (Rec−), are sensitive to DNA-damaging agents, and form small colonies, presumably stemming from a deficiency in recombinational repair of DNA breaks such as may arise from replication (Kuzminov 1999). In contrast, null mutations in recD abolish RecBCD ds and ss exonuclease activity (Nuc−) but not the helicase activity or the ability to load RecA onto ssDNA (Amundsen et al. 1986; Korangy and Julin 1993; Chen et al. 1998; Churchill et al. 1999). Because the nuclease active site is in RecB (Yu et al. 1998b), the RecD subunit must regulate the exonuclease activity. recD null mutants are Rec+, are barely more sensitive to DNA-damaging agents than wild type, and form large colonies. In these mutants, Chi is inactive (Chi−), and the resultant enzyme, called RecBC, is insensitive to Chi (Chaudhury and Smith 1984b; Amundsen et al. 1986; Yu et al. 1998a). This phenotype, Chi− Nuc− Rec+, is designated “double dagger” (‡). Certain recC mutations also have the ‡ phenotype; these mutants are altered in or lack the C-terminal domain of RecC that is necessary for the assembly of RecD into the holoenzyme (Amundsen et al. 2002). The recC mutations described here have a related but novel phenotype, Chi+ Nuc− Rec+, which we designate “dagger” (†). The intracellular phenotypes of recBCD mutants, and hence the intracellular activities of RecBCD, are readily assessed by growth (plaque formation) of certain phages and by genetic crosses. RecBCD's exonuclease activity blocks the growth of phage T4 gene 2 mutants: gene 2 protein is thought to bind to the ends of T4 DNA in the virion, and upon infection it protects the DNA from degradation by RecBCD exonuclease (Oliver and Goldberg 1977; Lipinska et al. 1989). Degradation of intracellular DNA is likely via a combination of the nuclease activity of the RecBCD molecule that unwinds the DNA (ds exonuclease) and that of other RecBCD molecules acting on the initially unwound DNA (ss exonuclease). Thus, T4 2− phage make plaques on cells lacking RecBCD nuclease activity, whether or not the cells are Rec+ (Amundsen et al. 1990). Chi activity and recombination proficiency can be measured quantitatively in crosses between phage λ red gam mutants, which lack the RecBCD inhibitory protein Gam and lack the λ recombination enzymes Red and thus rely upon the E. coli RecBCD pathway for recombination (reviewed by Smith 1983). Wild-type λ lacks Chi sites (designated χ0) and recombines at a low rate by the RecBCD pathway, but Chi mutations (designated χ+) locally stimulate this pathway. Chi hotspot activity is defined as the ratio of the recombinant frequency in an interval with Chi to that in the same interval without Chi (supplemental Table S3 at http://www.genetics.org/supplemental/); an increased ratio reflects the localized stimulation of recombination at and near Chi, the definition of a recombination hotspot. In the Chi assays reported here, we used two crosses designed by Stahl and Stahl (1977) that allow for normalization of the increased burst size of phages with Chi. A qualitative assay of Chi activity is the larger plaque size of λ red gam χ+ compared to that of λ red gam χ0 on lawns of cells with RecBCD exonuclease activity, which blocks the late (rolling circle) form of λ-replication. In this situation, λ red gam plaque formation is dependent on the RecBCD pathway of recombination to produce DNA that can be packaged into viable (plaque-forming) particles. In the absence of recombination, such as in E. coli recA mutants, no visible plaques are formed; with recombination (e.g., in recA+ recBCD+ cells) there are small plaques without Chi and large plaques with Chi (Smith 1983). Recombination can be assayed quantitatively as the frequency of recombinants in λ red gam phage crosses or in Hfr cellular crosses. Here, we use these assays to assess the intracellular activities of RecBCD exonuclease and Chi. The recC1041 nonsense allele lacks exonuclease activity but retains Chi hotspot activity: A strain with the recC1041 allele was isolated in a search for recBCD alleles with novel phenotypes (Amundsen et al. 2002). This isolate was Rec+ but sensitive to T4 2− phage and supported large plaque formation by λ red gam phage, both χ0 and χ+. The mutation was isolated on the F′15 factor, bearing the recBCD genes; after transfer of the mutation to the chromosome or to a high-copy-number plasmid, the phenotypes remained the same (see below). These phenotypes indicated that recC1041 cells lack RecBCD exonuclease activity, and, as expected, cell-free extracts lack detectable ATP-dependent ds exonuclease activity, the hallmark of RecBCD enzyme (Amundsen et al. 2002). Complementation and nucleotide sequence analysis showed that the mutation is a nonsense mutation in recC (Trp841 → UGA841), and the mutation was assigned to the category ‡ (Chi− Nuc− Rec+). Further quantitative crosses of phage λ showed, however, that the recC1041 mutant retains Chi activity (Table 2). In recBCD+ cells, Chi activity was ~5, indicating that the recombinant frequency was approximately five times higher in an interval with Chi than in the same interval without Chi (Stahl and Stahl 1977). In recB21 IS186 (null) cells, the hotspot value was essentially unity, indicating that Chi has no effect on the recombinant frequency in the intervals measured, as reported previously (Stahl and Stahl 1977). In recC1041 cells, the hotspot value was ~3. The hotspot values were similar whether recC1041 was on the chromosome, on an F′ factor, or on a derivative of plasmid pBR322 bearing the recBCD genes. In 43 experiments, the hotspot values in cells with plasmid-borne recC1041 ranged from 1.4 to 4.8; the mean ± SEM was 2.9 ± 0.2 (Tables 2 and 5–7; supplemental Table S3 at http://www.genetics.org/supplemental/, and additional data). This value was significantly >1 (P 0.001; one-sided t-test), indicating that Chi was active in these cells. As reported previously (Amundsen et al. 2002), recC1041 cells were recombination proficient in Hfr crosses and allowed plaque formation by phage T4 and its gene 2 mutant with high efficiency (Tables 2, 3, and 6).
The lower but readily observable Chi hotspot value in recC1041 cells compared to that in recBCD+ cells may be a consequence of a mixture of Chi-independent and Chi-dependent loading of RecA protein by enzyme from recC1041 cells (Amundsen et al. 2002). Like RecBC enzyme, enzyme from recC1041 cells loads RecA protein, even in the absence of Chi, onto the DNA end at which unwinding commences (Churchill et al. 1999; Amundsen et al. 2002). Furthermore, in the absence of RecBCD exonuclease, λ red gam phages can replicate to high levels in the rolling-circle mode; these forms may recombine by a Chi-independent pathway (Stahl and Stahl 1977; Smith 1983). Thus, RecBC1041D may form Chi-independent recombinants, as does RecBC (Chaudhury and Smith 1984b), If so, these recombinants would dilute the Chi-dependent recombinants, and the measured hotspot value would be decreased relative to that in recBCD+ cells. As noted above, the hotspot values and the recombinant frequencies were not significantly different if the recBCD alleles were on the chromosome or on a derivative of pBR322 (Table 2). Extracts of cells with the pBR322-borne recBCD+ genes contain ~25 times as much RecBCD enzyme activity as those of cells with the recBCD+ genes on the chromosome (Ponticelli et al. 1985). Thus, changing the level of RecBC1041D enzyme by a factor of ~25 (from plasmid-borne level to chromosomal level) did not detectably change Chi activity. As a direct assay of RecBCD exonuclease on λ red gam phages in recC1041 cells, we tested the ability of these phages to grow on recA mutant derivatives. λ red gam cannot recombine in recA mutants, and phage growth is blocked by RecBCD exonuclease (Smith 1983). We found that λ red gam χ0 and χ+ made large plaques with near unit efficiency on recC1041 ΔrecA kan cells (Table 3), indicating the lack of detectable RecBCD exonuclease even in cells with recC1041 on a derivative of the high-copy-number plasmid pBR322. As expected, λ red gam phage growth was blocked in ΔrecA kan recBCD+ cells, and T4 2− growth in recC+ or recC1041 cells was not affected by the ΔrecA kan mutation.Chi hotspot activity in recC1041 requires RecD polypeptide but not RecJ or ExoI ss exonuclease: Removal of RecD from wild-type RecBCD enzyme abolishes Chi activity (Chaudhury and Smith 1984b; Amundsen et al. 1986). To determine if RecD is also required for Chi activity in recC1041 cells, we coupled the recD1013 mutation with recC1041. recD1013 is a nonsense mutation (Gln4 → UAA4), which effectively eliminates RecD (Table 1). Chi was inactive in recC1041 recD1013, recC1041 ΔrecD, and recC+ recD1013 cells (Table 2). Thus, RecD is required for Chi activity in all situations reported to date (Chaudhury and Smith 1984b; Amundsen et al. 1986; see discussion). Although RecBCD is the most potent exonuclease in extracts of E. coli (our unpublished data), there are other nucleases that might influence Chi activity. Of particular importance is RecJ, a 5′→ 3′ ss exonuclease that is required for recombination in recD mutants (Lovett et al. 1988) and for recombination in the absence of RecBCD (and the presence of appropriate sbc suppressor mutations that activate the RecE or RecF pathway) (Lovett and Clark 1984). The recJ284 Tn10 (null) mutation did not significantly alter Chi hotspot activity in recC+ or recC1041 mutant cells (Table 4). Exonuclease I (ExoI), a 3′→5′ ss exonuclease, blocks recombination in recB or recC null mutants; the sbsB15 mutation, in conjunction with elimination of the SbcCD nuclease, suppresses this recombination deficiency to allow full activity of the RecF pathway (Smith 1988). The sbcB15 missense mutation greatly reduces ExoI nuclease activity (Phillips et al. 1988), but the mutant protein may retain the DNA-binding activity and thereby block access of other nucleases, whereas the ΔxonA allele deletes the gene (Feschenko et al. 2003). The sbsB15 or ΔxonA mutation had no effect on, or only slightly reduced, Chi hotspot activity in recBCD+, recC1041, recJ284, or recC1041 recJ284 strains (Table 4). Razavy et al. (1996) also reported high Chi activity in recBCD+ strains bearing recJ284, ΔxonA, and sbcB15 mutations, singly or in combinations. Thus, RecBCD ds exonuclease and the RecJ and ExoI ss exonucleases are not required for Chi activity in recC1041 cells.
An rpsL mutation does not alter the recC1041 phenotype: Although changing the level of RecBC1041D had no significant effect on Chi activity (see above), we entertained the possibility of low-level translational “readthrough” of the recC1041 UGA codon. Such readthrough would produce full-length RecC polypeptide and potentially wild-type RecBCD enzyme, which would be expected to manifest Chi activity and exonuclease activity. The strains used in Tables 2, 3, and 4 and in supplemental Table S3 at http://www.genetics.org/supplemental/ contain the rpsL31 mutation; rpsL mutations confer resistance to streptomycin and often reduce readthrough (Dong and Kurland 1995). We found that these strains and the rpsL+ and rpsL222 derivatives of them all had Chi hotspot activity (Table 5) and were sensitive to T4 2−. The rpsL222 mutation reduces readthrough of lacZ UGA nonsense mutations by a factor of 10–40 (Dong and Kurland 1995). The lack of a sufficiently sensitive assay for RecC polypeptide precludes a direct measure of low-level readthrough of recC1041 (also see below). These results argue against the observed Chi activity being due to readthrough of recC1041 that produces a low level of wild-type RecBCD enzyme. recC1041 is epistatic to recC1010, a distal Chi− missense mutation: The recC1010 mutation (Gly905 → Glu905) alters a domain in RecC required for the assembly of RecD into the RecBCD holoenzyme complex and consequently confers the Chi− Nuc− Rec+ (‡) phenotype (Amundsen et al. 2002). As an additional test of the possibility of readthrough from recC1041, we coupled recC1041 (Trp841 → UGA841) and recC1010, which are in the order 5′–C1041–C1010–3′. In this double mutant, any readthrough RecC polypeptide would have Glu905 and would be expected to have the Chi− Nuc− Rec+ phenotype. We found, however, that Chi was active in this double mutant (Table 6). As expected, introduction of a UGA suppressor (Su9) to permit readthrough led to the loss of Chi activity but retention of high efficiency of plaque formation by T4 2− phage, i.e., the recC1010 Chi− Nuc− Rec+ (‡) phenotype. These results further indicate that there is little, if any, readthrough of recC1041. A set of recC C-terminal deletions with Chi hotspot activity: Since recC1041 is a nonsense mutation, deletions of the 3′-end of recC are expected to produce the same phenotype. We previously described a set of ExoIII-generated deletions of recC (Amundsen et al. 2002), some of which are illustrated in Figure 3 We next constructed a deletion whose endpoint is immediately after the recC1041 UGA841nonsense codon and an additional nonsense codon UGA842. As expected, cells with this deletion, recC2725, had Chi hotspot activity (Table 7) and were sensitive to T4 2− phage. Another deletion, recC2726, identical to recC2725 except for the stronger stop codon UAA842 and 6 bp with a KpnI site used for cloning, also conferred Chi hotspot activity. These results confirm that elimination of the RecC C terminus can abolish RecBCD exonuclease activity without abolishing Chi hotspot activity. In some cases, cultures of cells with these plasmid-borne recC deletions were unstable, as is often the case for plasmids in recBCD Nuc− mutants (Biek and Cohen 1986; Cohen and Clark 1986). These cultures sometimes appeared Rec− and lacked Chi activity (i.e., had the recC null phenotype) or failed to grow in ampicillin-containing media selective for the plasmids, but in no case were the cells Rec+ Chi−. For example, among 10 parallel cultures started from isolated colonies of a strain with the recC2725 mutation, 4 had Chi activity, ranging from 2.1 to 3.4 (mean ± SEM = 2.5 ± 0.3); these cultures also produced a higher frequency of λ J+ R+ recombinants than the other cultures (2.6 ± 0.6% vs. 1.2 ± 0.4%). Among subcultures of these 10 cultures, tested the next day, one remained Chi+ and two previously without Chi activity gained it, ranging from 2.3–3.3 (2.9 ± 0.3); again, the Chi+ cultures were more recombination proficient (3.1 ± 0.1% vs. 1.1 ± 0.2%). We suspect that, in the absence of RecBCD exonuclease activity, these plasmids enter rolling-circle replication, with consequent loss of recBCD or bla (ampicillin-resistance determinant) genes or their expression or consequent sequestration of RecBCD enzyme by the linear DNA. Cultures with plasmid-borne recC1041 were more stable. For example, 10 parallel cultures all had Chi activity, ranging from 1.6 to 3.2 (2.5 ± 0.2) on the first day and from 1.4 to 4.2 (3.3 ± 0.3) on the subsequent day. The basis of instability of the recC deletion plasmids is unclear, but all cultures tested allowed plaque formation by T4 2−, indicating that they lacked RecBCD exonuclease activity even when Chi activity was observed. Enzyme purified from recC1041 cells has Chi-nicking and RecA-loading activities but no detectable exonuclease activity: Enzyme purified from recC1041 cells has stoichiometric amounts of the RecB and RecC polypeptides but <0.03 mol-equivalents of RecD polypeptide (our unpublished data), as expected from the lack of the RecC domain required for RecD assembly into the holoenzyme (Amundsen et al. 2002). The requirement for RecD for hotspot activity in recC1041 cells (Table 2) presents a paradox that we address in the discussion. The mutant RecC polypeptide has an apparent mass of ~95 kDa, as determined by SDS–polyacrylamide gel electrophoresis and as expected from the truncation at codon 840 of 1122 in recC+ (Amundsen et al. 2002). This purified enzyme has no detectable exonuclease activity (Amundsen et al. 2002). The retention of Chi hotspot activity but not RecBCD exonuclease in recC1041 cells suggested that the enzyme in recC1041 cells has Chi-nicking and RecA-loading activities. With enzyme purified from these cells, Chi nicking activity was observed on two different linear DNA substrates derived from pBR322, one with χ+F (Figure 4
DISCUSSION Current models for the action of RecBCD enzyme at Chi and the consequent local stimulation of recombination (Chi hotspot activity) differ in the role of the RecBCD nuclease. In one view, RecBCD enzyme nicks DNA at Chi (Smith et al. 1981b; Smith 1991, 2001), whereas, in another view, the enzyme uses its ds exonuclease activity to degrade one strand up to Chi and then switches the nuclease to the other strand (Thaler et al. 1988; Stahl et al. 1990; Kuzminov et al. 1994; Myers and Stahl 1994; Anderson and Kowalczykowski 1997b). Here, we show that a novel class of recBCD mutants lacking detectable ds exonuclease activity retains Chi activity. These mutants and their phenotypes have multiple implications for the function of RecBCD enzyme and its role in recombination. Nucleolytic degradation is not necessary for Chi hotspot activity: The properties of the recC Chi+ Nuc− Rec+ (†) mutants described here are not expected from the view that Chi stops DNA degradation by RecBCD, since Chi activity was retained in mutants that lack detectable ds exonuclease activity (Tables 2–7 and supplemental Table S3 at http://www.genetics.org/supplemental/; Amundsen et al. 2002). Although a very low level of RecBCD exonuclease in these mutants cannot be excluded, there is not sufficient exonuclease activity to block the growth of T4 gene 2− phage or λ red gam phage in recA derivatives (Tables 2, 3, and 6). Since there is ~5 kb of redundant DNA at the ends of T4 virion DNA, DNA degradation must be <5 kb to allow plaque formation by a phage DNA molecule injected into the cell. The amount of DNA degradation required to block the switch from θ-form replication to rolling-circle (σ) replication of λ is unknown but may be <1 kb. In the λ phages used to measure Chi activity, the Chi sites (χ+D and χ+76) were located 3.5 and 15.5 kb from the entry site for RecBCD (Stahl and Stahl 1977; Smith et al. 1981a; Kobayashi et al. 1982), and both were active in the recC Chi+ Nuc− Rec+ (†) mutants (Tables 2 and 4–7; supplemental Table S3 at http://www.genetics.org/supplemental/). Thus, RecBC1041D enzyme can travel >15 kb from a DNA end and productively interact with Chi. These data argue against there being sufficient RecBCD exonuclease activity to degrade DNA up to Chi in crosses in the recC† mutants studied here. Previous evidence also argues that the reaction condition under which purified RecBCD nicks at Chi (excess ATP) more nearly reflects the behavior of RecBCD and Chi in cells. Purified RecBCD enzyme, after acting at a Chi site, loses nuclease and Chi-nicking activity on a second DNA substrate, provided the reaction contains excess ATP over Mg2+ (Taylor and Smith 1992, 1999), the condition that favors nicking at Chi. The three subunits disassemble, perhaps at the end of the first DNA substrate, and the enzyme remains inactive for >2 hr but can be reactivated by reassembly upon addition of excess Mg2+. If Mg2+ is in excess from the start of the reaction, no inactivation is observed, and the enzyme acts at Chi on a second DNA substrate. In E. coli cells, if RecBCD is exposed to linearized plasmid DNA with Chi, it manifests reduced Chi activity in λ crosses (Myers et al. 1995). Similarly, treatment of recBCD+ cells with bleomycin, which can produce dsDNA breaks and allow RecBCD to interact with the chromosomal Chi sites, subsequently leads to productive T4 2− infections and loss of Chi activity in λ crosses (Köppen et al. 1995). Thus, the reaction condition favoring nicking at Chi readily accounts for the reduction or loss of RecBCD activities in cells. A consideration of the reciprocality of recombination also argues, albeit not conclusively, against degradation up to Chi. For a single recombination event between two parental DNA molecules to produce the two reciprocal recombinant types, neither DNA substrate can be extensively degraded, since that would result in marker loss. The reaction condition favoring degradation up to Chi destroys one or the other strand to each side of Chi (Figure 1
A model for recombination incorporating nicking at Chi and loading of RecA protein: The properties of the recC Chi+ Nuc− Rec+ (†) mutants are consistent with models in which RecBCD enzyme nicks DNA at Chi (Smith et al. 1981b; Smith 1991, 2001) and thereafter loads RecA protein onto the 3′ Chi tail (Anderson and Kowalczykowski 1997b), since these activities were retained in the mutants (Figure 4 Support for this model comes from a variety of genetic and enzymological studies. In genetic assays, mutants lacking the enzymes noted above are deficient for recombination involving linear dsDNA, as occurs in λ red gam crosses, Hfr crosses, and P1 transductions (reviewed by Smith 1983, 1988). Chi is active in such crosses, and mutations in recC or in the Chi sequence specifically block Chi hotspot activity (Stahl et al. 1975; Dower and Stahl 1981; Schultz et al. 1981, 1983). Biochemical studies with purified proteins have demonstrated the activities of the individual enzymes noted above (reviewed by Smith 1988, 2001; Kowalczykowski et al. 1994; Kowalczykowski 2000). Mutations that alter RecBCD or Chi coordinately alter Chi nicking (Ponticelli et al. 1985; Taylor et al. 1985; Cheng and Smith 1987) or switching of DNA degradation from one strand to the other at Chi (Dixon and Kowalczykowski 1993; Taylor and Smith 1995b; Anderson and Kowalczykowski 1997a). These results are consistent with both models in Figure 1 The intracellular role of RecBCD exonuclease: If RecBCD's exonuclease is not necessary for Chi activity, what is its physiological role? Degradation of intracellular DNA by RecBCD has been observed in several situations. These include degradation of λ DNA subjected to restriction endonucleases (Simmon and Lederberg 1972), T4 gene 2 mutant DNA (Oliver and Goldberg 1977), and UV-irradiated DNA in recA mutants (“reckless degradation”; Clark et al. 1966). In each of these situations, the DNA cannot recombine with intact DNA. We have proposed that RecBCD's exonuclease degrades DNA that cannot recombine (Smith 2001). DNA that does recombine would become circular, losing the DNA end required for RecBCD enzyme activity (Goldmark and Linn 1972). It has been proposed that Chi protects intracellular DNA from degradation by RecBCD. For example, switching a plasmid into rolling-circle replication leads to high-molecular-weight forms of the DNA only if the plasmid contains Chi; this result was interpreted to mean that Chi protects the linear branch of the rolling circle from degradation by RecBCD (Dabert et al. 1992). However, formation of high-molecular-weight DNA also requires RecA protein. We propose that in these cells a nascent rolling circle recombines with another circular plasmid, in a Chi–RecBCD–RecA-dependent manner, to produce a “dumbbell-shaped” molecule, which would lack a DNA end and be resistant to RecBCD exonuclease. In another example, Chi partially protects linearized plasmid DNA from RecBCD, both in cis (i.e., the DNA with Chi) and in trans (i.e., the DNA of a separate linearized plasmid; Kuzminov et al. 1994). As in the previous example, Chi's protection was seen only in recA+ cells and may reflect recombination between plasmids. The role of RecD polypeptide in RecBCD enzyme: Since its discovery (Amundsen et al. 1986; Biek and Cohen 1986), the RecD polypeptide has presented mysteries. The sequence of the recD gene suggested that RecD is a helicase (Gorbalenya et al. 1988; Hodgman 1988), but that activity was demonstrated only much later (Dillingham et al. 2003; Taylor and Smith 2003). The initial reports of recD mutants showed that they lack RecBCD nuclease activity (Chaudhury and Smith 1984b; Amundsen et al. 1986). This result was interpreted by some investigators to mean that the nuclease active site resides in RecD, but that site clearly resides in RecB (Yu et al. 1998a,b). Nevertheless, RecBC enzyme has <1/1000 of the ds and ss exonuclease activity of the wild-type enzyme (Yu et al. 1998a). Thus, RecD must regulate the nuclease activity. RecA loading by RecBCD is inhibited by RecD until the enzyme responds to a Chi- and nuclease-dependent signal (Churchill et al. 1999; Amundsen et al. 2000). The physical basis by which RecD regulates RecBCD remains unknown. To our knowledge, RecD is required for Chi hotspot activity in all situations reported to date. RecD is required for Chi activity in otherwise wild-type cells (Chaudhury and Smith 1984b; Amundsen et al. 1986) and in the recC Chi+ Nuc− Rec+ (†) mutants (Table 2). In extracts of wild-type cells, RecD is associated with the holoenzyme complex, but in extracts of the recC† mutants, it is not detectably associated with the RecBC† complex (Amundsen et al. 1986, 2002). These results are consistent with the recC† mutants lacking a domain of RecC required for the assembly of RecD into the holoenzyme (Amundsen et al. 2002; Figure 2 A segment of RecC that inhibits Chi activity: The region of RecC between amino acids ~790 and ~922 appears to inhibit Chi activity, at least in the absence of the RecC C-terminal ~150 amino acids. Chi was inactive in recC mutants lacking the extreme C terminus, defined by the endpoints of recC2714 and recC2710, but not in more extensive deletions (Figure 3 Acknowledgments We are grateful to Sue Lovett for the ΔxonA kan allele; to Gareth Cromie, Jon Gallant, Manjula Reddy, Dennis Schultz, and Andrew Taylor for discussions and valuable suggestions; to Andrew Taylor for Figure 2References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||
Trends Biochem Sci. 2000 Apr; 25(4):156-65.
[Trends Biochem Sci. 2000]Annu Rev Genet. 2001; 35():243-74.
[Annu Rev Genet. 2001]Genes Dev. 1997 Mar 1; 11(5):571-81.
[Genes Dev. 1997]Cell. 1980 Nov; 22(2 Pt 2):447-57.
[Cell. 1980]J Biol Chem. 1995 Oct 13; 270(41):24451-8.
[J Biol Chem. 1995]Mol Gen Genet. 1997 Apr 16; 254(3):319-29.
[Mol Gen Genet. 1997]Nature. 2003 Jun 19; 423(6942):889-93.
[Nature. 2003]J Biol Chem. 1992 Feb 25; 267(6):4207-14.
[J Biol Chem. 1992]Cell. 1985 May; 41(1):145-51.
[Cell. 1985]Cell. 1985 May; 41(1):153-63.
[Cell. 1985]J Biol Chem. 1995 Oct 13; 270(41):24459-67.
[J Biol Chem. 1995]Cell. 1993 Apr 9; 73(1):87-96.
[Cell. 1993]Genes Dev. 1997 Mar 1; 11(5):571-81.
[Genes Dev. 1997]Experientia. 1981; 37(8):846-7.
[Experientia. 1981]Genetics. 1989 Sep; 123(1):5-17.
[Genetics. 1989]Microbiol Rev. 1988 Mar; 52(1):1-28.
[Microbiol Rev. 1988]Virology. 1976 Jul 1; 72(1):195-211.
[Virology. 1976]Genetics. 1977 Aug; 86(4):715-25.
[Genetics. 1977]Genetics. 1977 Aug; 86(4):715-25.
[Genetics. 1977]J Bacteriol. 1983 Aug; 155(2):664-80.
[J Bacteriol. 1983]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Cell. 1985 May; 41(1):153-63.
[Cell. 1985]Microbiol Mol Biol Rev. 1999 Dec; 63(4):751-813, table of contents.
[Microbiol Mol Biol Rev. 1999]Proc Natl Acad Sci U S A. 1986 Aug; 83(15):5558-62.
[Proc Natl Acad Sci U S A. 1986]Biochemistry. 1993 May 11; 32(18):4873-80.
[Biochemistry. 1993]J Mol Biol. 1998 Apr 24; 278(1):89-104.
[J Mol Biol. 1998]Genes Dev. 1999 Apr 1; 13(7):901-11.
[Genes Dev. 1999]J Mol Biol. 1977 Nov; 116(4):877-81.
[J Mol Biol. 1977]J Bacteriol. 1989 Jan; 171(1):488-97.
[J Bacteriol. 1989]Genetics. 1990 Sep; 126(1):25-40.
[Genetics. 1990]Genetics. 1977 Aug; 86(4):715-25.
[Genetics. 1977]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Genetics. 1977 Aug; 86(4):715-25.
[Genetics. 1977]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Genes Dev. 1999 Apr 1; 13(7):901-11.
[Genes Dev. 1999]Genetics. 1977 Aug; 86(4):715-25.
[Genetics. 1977]Proc Natl Acad Sci U S A. 1984 Dec; 81(24):7850-4.
[Proc Natl Acad Sci U S A. 1984]Cell. 1985 May; 41(1):145-51.
[Cell. 1985]Proc Natl Acad Sci U S A. 1984 Dec; 81(24):7850-4.
[Proc Natl Acad Sci U S A. 1984]Proc Natl Acad Sci U S A. 1986 Aug; 83(15):5558-62.
[Proc Natl Acad Sci U S A. 1986]Genetics. 1988 Sep; 120(1):37-45.
[Genetics. 1988]J Bacteriol. 1984 Jan; 157(1):190-6.
[J Bacteriol. 1984]Microbiol Rev. 1988 Mar; 52(1):1-28.
[Microbiol Rev. 1988]J Bacteriol. 1988 May; 170(5):2089-94.
[J Bacteriol. 1988]Proc Natl Acad Sci U S A. 2003 Feb 4; 100(3):1134-9.
[Proc Natl Acad Sci U S A. 2003]J Mol Biol. 1995 May 5; 248(3):551-61.
[J Mol Biol. 1995]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]J Bacteriol. 1986 Aug; 167(2):594-603.
[J Bacteriol. 1986]J Bacteriol. 1986 Jul; 167(1):327-35.
[J Bacteriol. 1986]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]J Biol Chem. 1995 Oct 13; 270(41):24451-8.
[J Biol Chem. 1995]J Biol Chem. 1997 Apr 11; 272(15):10072-9.
[J Biol Chem. 1997]Nature. 2004 Nov 11; 432(7014):187-93.
[Nature. 2004]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Cell. 1991 Jan 11; 64(1):19-27.
[Cell. 1991]Annu Rev Genet. 2001; 35():243-74.
[Annu Rev Genet. 2001]Genetics. 1990 Nov; 126(3):519-33.
[Genetics. 1990]EMBO J. 1994 Jun 15; 13(12):2764-76.
[EMBO J. 1994]Annu Rev Genet. 1994; 28():49-70.
[Annu Rev Genet. 1994]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Genetics. 1977 Aug; 86(4):715-25.
[Genetics. 1977]J Virol. 1981 Jan; 37(1):336-42.
[J Virol. 1981]Proc Natl Acad Sci U S A. 1982 Oct; 79(19):5981-5.
[Proc Natl Acad Sci U S A. 1982]Proc Natl Acad Sci U S A. 1992 Jun 15; 89(12):5226-30.
[Proc Natl Acad Sci U S A. 1992]Genes Dev. 1999 Apr 1; 13(7):890-900.
[Genes Dev. 1999]Proc Natl Acad Sci U S A. 1995 Jul 3; 92(14):6244-8.
[Proc Natl Acad Sci U S A. 1995]Proc Natl Acad Sci U S A. 1995 Jul 3; 92(14):6249-53.
[Proc Natl Acad Sci U S A. 1995]Cell. 1997 Jul 11; 90(1):77-86.
[Cell. 1997]Proc Natl Acad Sci U S A. 1976 Dec; 73(12):4613-7.
[Proc Natl Acad Sci U S A. 1976]Genetics. 1982 Dec; 102(4):599-613.
[Genetics. 1982]Genetics. 1984 Dec; 108(4):795-808.
[Genetics. 1984]Genetics. 1984 Dec; 108(4):773-94.
[Genetics. 1984]Cell. 1991 Jan 11; 64(1):19-27.
[Cell. 1991]Annu Rev Genet. 2001; 35():243-74.
[Annu Rev Genet. 2001]Cell. 1997 Jul 11; 90(1):77-86.
[Cell. 1997]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Trends Biochem Sci. 2000 Apr; 25(4):156-65.
[Trends Biochem Sci. 2000]Microbiol Rev. 1988 Mar; 52(1):1-28.
[Microbiol Rev. 1988]J Mol Biol. 1975 May 15; 94(2):203-12.
[J Mol Biol. 1975]Proc Natl Acad Sci U S A. 1981 Nov; 78(11):7033-7.
[Proc Natl Acad Sci U S A. 1981]J Mol Biol. 1981 Mar 5; 146(3):275-86.
[J Mol Biol. 1981]J Bacteriol. 1983 Aug; 155(2):664-80.
[J Bacteriol. 1983]J Bacteriol. 1972 Oct; 112(1):161-9.
[J Bacteriol. 1972]J Mol Biol. 1977 Nov; 116(4):877-81.
[J Mol Biol. 1977]J Mol Biol. 1966 Aug; 19(2):442-54.
[J Mol Biol. 1966]Annu Rev Genet. 2001; 35():243-74.
[Annu Rev Genet. 2001]J Biol Chem. 1972 Mar 25; 247(6):1849-60.
[J Biol Chem. 1972]Proc Natl Acad Sci U S A. 1992 Dec 15; 89(24):12073-7.
[Proc Natl Acad Sci U S A. 1992]EMBO J. 1994 Jun 15; 13(12):2764-76.
[EMBO J. 1994]Proc Natl Acad Sci U S A. 1986 Aug; 83(15):5558-62.
[Proc Natl Acad Sci U S A. 1986]J Bacteriol. 1986 Aug; 167(2):594-603.
[J Bacteriol. 1986]FEBS Lett. 1988 Aug 1; 235(1-2):16-24.
[FEBS Lett. 1988]Nature. 2003 Jun 19; 423(6942):889-93.
[Nature. 2003]Proc Natl Acad Sci U S A. 1984 Dec; 81(24):7850-4.
[Proc Natl Acad Sci U S A. 1984]Proc Natl Acad Sci U S A. 1984 Dec; 81(24):7850-4.
[Proc Natl Acad Sci U S A. 1984]Proc Natl Acad Sci U S A. 1986 Aug; 83(15):5558-62.
[Proc Natl Acad Sci U S A. 1986]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Nature. 2004 Nov 11; 432(7014):187-93.
[Nature. 2004]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Proc Natl Acad Sci U S A. 2000 Jun 20; 97(13):7399-404.
[Proc Natl Acad Sci U S A. 2000]Annu Rev Genet. 2001; 35():243-74.
[Annu Rev Genet. 2001]Genetics. 2002 Jun; 161(2):483-92.
[Genetics. 2002]Mol Gen Genet. 1988 Jul; 213(1):144-9.
[Mol Gen Genet. 1988]